Chuan-Xin Huang
Overview
Explore the profile of Chuan-Xin Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
401
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng Z, Wang J, Sun R, Wang N, Weng X, Xu T, et al.
Signal Transduct Target Ther
. 2025 Jan;
10(1):29.
PMID: 39828715
Immunomodulatory agent lenalidomide is effective in treating follicular lymphoma (FL). We conducted the first trial of immunotherapy rituximab plus lenalidomide in newly diagnosed FL in China (NCT03715309). One-hundred and fifteen...
2.
Liu Q, Zhu Y, Yi H, Shen Y, Wang L, Cheng S, et al.
Int J Biol Sci
. 2024 Aug;
20(10):3972-3985.
PMID: 39113693
Histone methyltransferase is one of the most frequently mutated genes in diffuse large B-cell lymphoma (DLBCL) and has been identified as an important pathogenic factor and prognostic marker. However, the...
3.
Shen Y, Ji M, Yi H, Shen R, Fu D, Cheng S, et al.
Clin Transl Med
. 2024 Jan;
14(1):e1532.
PMID: 38193627
No abstract available.
4.
Sun R, Zhang P, Weng X, Gao X, Huang C, Wang L, et al.
Signal Transduct Target Ther
. 2022 Mar;
7(1):80.
PMID: 35301282
MicroRNAs (miRNAs) are involved in lymphoma progression by regulating the tumor microenvironment. Serum miR130b is overexpressed in diffuse large B-cell lymphoma (DLBCL), inducing Th17 cell alterations. To further illustrate its...
5.
Zhou X, Li X, Liao L, Han J, Huang J, Li J, et al.
Acta Pharmacol Sin
. 2021 Apr;
43(2):457-469.
PMID: 33850273
Mantle cell lymphoma (MCL) is a lymphoproliferative disorder lacking reliable therapies. PI3K pathway contributes to the pathogenesis of MCL, serving as a potential target. However, idelalisib, an FDA-approved drug targeting...
6.
Huang Y, Cai K, Xu P, Wang L, Huang C, Fang Y, et al.
Signal Transduct Target Ther
. 2021 Jan;
6(1):10.
PMID: 33431788
Epigenetic alterations play an important role in tumor progression of diffuse large B-cell lymphoma (DLBCL). However, the biological relevance of epigenetic gene mutations on tumor microenvironment remains to be determined....
7.
Song Z, Reitman Z, Ma Z, Chen J, Zhang Q, Shou X, et al.
Cell Res
. 2016 Sep;
26(11):1255-1259.
PMID: 27670697
No abstract available.
8.
Ma Z, Song Z, Chen J, Wang Y, Li S, Zhou L, et al.
Cell Res
. 2015 Feb;
25(3):306-17.
PMID: 25675982
Cushing's disease, also known as adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas (PAs) that cause excess cortisol production, accounts for up to 85% of corticotrophin-dependent Cushing's syndrome cases. However, the genetic alterations...
9.
Yao Y, Ding X, Jia Y, Huang C, Wang Y, Xu Y
Cancer Lett
. 2008 Apr;
264(1):127-34.
PMID: 18442668
beta-Elemene, a natural plant drug extracted from Curcuma wenyujin, has been used as an antitumor drug for different tumors, including glioblastoma. However, the mechanism of its anti-tumor effect is largely...
10.
Yu Z, Li Y, Huang C, Chu R, Hu D, Shen Z, et al.
Zhonghua Yan Ke Za Zhi
. 2007 Jul;
43(3):233-8.
PMID: 17605906
Objective: Pathological myopia has a genetic background. Previous studies have mapped six loci at 18p11.31, 12q21-23, 7q36, 17q21-22, 4q22-q27 and 2q37.1 in autosomal dominant (AD) pathological myopia. The aim of...